Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-23-048222

Options or other derivatives

  • President, CEO and Chairperson acquired 2,100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Shah Pratik President, CEO and Chairperson 2023-09-01 Grant or award · Stock Option (right to buy) +1,050,000 1,050,000 D: show line 1 in the form
Shah Pratik President, CEO and Chairperson 2023-09-01 Grant or award · Stock Option (right to buy) +525,000 525,000 D: show line 2 in the form
Shah Pratik President, CEO and Chairperson 2023-09-01 Grant or award · Stock Option (right to buy) +525,000 525,000 D: show line 3 in the form
Loading xslF345X05/doc4.xml…